Nicholas Lydon Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nicholas Lydon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nicholas Lydon. Nicholas Lydon is Director in ANAPTYSBIO INC ($ANAB) and Director in Blueprint Medicines Corp ($BPMC).
Latest Insider Trading Transactions of Nicholas Lydon
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 21 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.00 | 500 | 40,000 | 47,240 | 47.7 K to 47.2 K (-1.05 %) |
Jul 08 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 81.02 | 600 | 48,612 | 47,740 | 48.3 K to 47.7 K (-1.24 %) |
Jul 08 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.44 | 25,407 | 2,043,739 | 48,340 | 73.7 K to 48.3 K (-34.45 %) |
Jul 06 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.13 | 2,825 | 226,367 | 73,747 | 76.6 K to 73.7 K (-3.69 %) |
Jul 06 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.21 | 1,300 | 104,273 | 76,572 | 77.9 K to 76.6 K (-1.67 %) |
Jun 26 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
Jun 26 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Grant | A | 0.00 | 2,250 | 0 | 77,872 | 75.6 K to 77.9 K (+2.98 %) |
Jun 25 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.00 | 400 | 32,000 | 75,622 | 76 K to 75.6 K (-0.53 %) |
Jun 23 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
Jun 23 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 80.29 | 13,017 | 1,045,135 | 76,022 | 89 K to 76 K (-14.62 %) |
Jun 23 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Buy | M | 0.00 | 1,312 | 0 | 89,039 | 87.7 K to 89 K (+1.50 %) |
May 19 2020 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Gift | G | 0.00 | 20,000 | 0 | 87,727 | 107.7 K to 87.7 K (-18.57 %) |
Aug 21 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Gift | G | 0.00 | 20,000 | 0 | 107,727 | 127.7 K to 107.7 K (-15.66 %) |
Jun 20 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
Jun 20 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
Jun 17 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 90.36 | 25,000 | 2,259,000 | 127,727 | 152.7 K to 127.7 K (-16.37 %) |
Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 81.96 | 300 | 24,588 | 152,727 | 153 K to 152.7 K (-0.20 %) |
Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 82.45 | 2,000 | 164,900 | 153,027 | 155 K to 153 K (-1.29 %) |
Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 83.83 | 5,200 | 435,916 | 155,027 | 160.2 K to 155 K (-3.25 %) |
Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 84.66 | 6,300 | 533,358 | 160,227 | 166.5 K to 160.2 K (-3.78 %) |
Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 85.75 | 11,200 | 960,400 | 166,527 | 177.7 K to 166.5 K (-6.30 %) |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | A | 68.89 | 6,000 | 413,340 | 6,000 | |
Jun 25 2018 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 69.79 | 7,500 | 523,425 | 29,318 | |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 90.26 | 2,222 | 200,549 | 271,106 | 273.3 K to 271.1 K (-0.81 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 89.42 | 2,803 | 250,631 | 273,328 | 276.1 K to 273.3 K (-1.02 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 88.30 | 4,250 | 375,267 | 276,131 | 280.4 K to 276.1 K (-1.52 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 87.46 | 9,425 | 824,341 | 280,381 | 289.8 K to 280.4 K (-3.25 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 86.15 | 1,390 | 119,753 | 289,806 | 291.2 K to 289.8 K (-0.48 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 85.11 | 10,310 | 877,491 | 291,196 | 301.5 K to 291.2 K (-3.42 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 84.18 | 2,600 | 218,880 | 301,506 | 304.1 K to 301.5 K (-0.85 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 90.26 | 2,222 | 200,549 | 271,106 | 273.3 K to 271.1 K (-0.81 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 89.42 | 2,803 | 250,631 | 273,328 | 276.1 K to 273.3 K (-1.02 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 88.30 | 4,250 | 375,267 | 276,131 | 280.4 K to 276.1 K (-1.52 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 87.46 | 9,425 | 824,341 | 280,381 | 289.8 K to 280.4 K (-3.25 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 86.15 | 1,390 | 119,753 | 289,806 | 291.2 K to 289.8 K (-0.48 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 85.11 | 10,310 | 877,491 | 291,196 | 301.5 K to 291.2 K (-3.42 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 84.18 | 2,600 | 218,880 | 301,506 | 304.1 K to 301.5 K (-0.85 %) |
Feb 20 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | M | 4.55 | 16,483 | 74,998 | 0 | |
Feb 20 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Buy | M | 4.55 | 16,483 | 74,998 | 304,106 | 287.6 K to 304.1 K (+5.73 %) |
Feb 06 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | A | 104.81 | 6,000 | 628,860 | 6,000 | |
Jun 23 2017 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 21,818 | |
Mar 16 2017 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 39.72 | 1,400 | 55,608 | 202,727 | 204.1 K to 202.7 K (-0.69 %) |
Mar 16 2017 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 40.06 | 68,600 | 2,748,116 | 204,127 | 272.7 K to 204.1 K (-25.15 %) |
Feb 28 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | A | 24.60 | 15,000 | 369,000 | 15,000 | |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | C | 0.00 | 67,345 | 0 | 0 | |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | C | 0.00 | 55,403 | 0 | 0 | |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | C | 0.00 | 80,877 | 0 | 0 | |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Buy | P | 15.00 | 16,666 | 249,990 | 287,623 | 271 K to 287.6 K (+6.15 %) |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Buy | C | 0.00 | 203,625 | 0 | 270,957 | 67.3 K to 271 K (+302.42 %) |
Jun 27 2016 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 10,909 |
Page: 1